Provided by Tiger Trade Technology Pte. Ltd.

Seer, Inc.

1.68
-0.0450-2.61%
Post-market: 1.680.00000.00%16:59 EDT
Volume:263.20K
Turnover:444.96K
Market Cap:94.50M
PE:-1.31
High:1.73
Open:1.73
Low:1.68
Close:1.73
52wk High:2.41
52wk Low:1.62
Shares:56.25M
Float Shares:39.55M
Volume Ratio:1.31
T/O Rate:0.67%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.2812
EPS(LYR):-1.2812
ROE:-25.08%
ROA:-14.71%
PB:0.36
PE(LYR):-1.31

Loading ...

Bradley L. Radoff and Michael Torok: Urge Co's Board to Immediately Commence Sale Process of Co

THOMSON REUTERS
·
Feb 23

the Radoff-Jec Group Issues Open Letter to Seer Inc.’s Board of Directors Regarding the Immediate Need for Significant Change

THOMSON REUTERS
·
Feb 23

Radoff-JEC Group urges Seer board to pursue major changes ahead of shareholder meeting

Reuters
·
Feb 23

Top Executives Make Bold Moves in Latest Seer Insider Trading Activity

TIPRANKS
·
Feb 20

Seer announces participation at 2026 U.S. HUPO

TIPRANKS
·
Feb 19

Seer Showcases Proteograph Product Suite at US HUPO 2026 Annual Conference

Reuters
·
Feb 19

Seer to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

GlobeNewswire
·
Feb 06

RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE® (lazertinib) delivers statistically significant and clinically meaningful improvement in overall survival benefit for Asian patients with EGFR-mutated non-small cell lung cancer in the Phase 3 MARIPOSA study

prnewswire
·
Dec 08, 2025

Nature Genetics Study Validates Seer’s Proteograph Platform as Essential for Turning Genetic Signals Into Reliable Drug Targets and Biomarkers

GlobeNewswire
·
Dec 01, 2025

Seer, Inc. Earnings Call: Achievements Amid Challenges

TIPRANKS
·
Nov 08, 2025

Seer Inc. Showcases Deep Proteomics Advances at HUPO World Congress

Reuters
·
Nov 07, 2025

Life sciences company Seer's Q3 net loss narrows

Reuters
·
Nov 07, 2025

Seer Q3 EPS USD -0.32

Reuters
·
Nov 07, 2025

Seer Q3 EPS $(0.32) Misses $(0.31) Estimate, Sales $4.121M Beat $4.000M Estimate

Benzinga
·
Nov 07, 2025

Seer Inc. reports Q3 revenue of $4.1 million

Reuters
·
Nov 07, 2025

Seer Reports Third Quarter 2025 Financial Results

GlobeNewswire
·
Nov 07, 2025

Seer Inc expected to post a loss of 30 cents a share - Earnings Preview

Reuters
·
Nov 05, 2025

Seer Inc. to Participate in UBS Global Healthcare Conference

Reuters
·
Oct 30, 2025

Seer to Report Third Quarter 2025 Financial Results on November 6, 2025

GlobeNewswire
·
Oct 17, 2025

RetinalGenix Technologies contracts Seer Bio to advance early detection of neurodegenerative systemic and retinal diseases

Reuters
·
Oct 16, 2025